A new study in mice found that a treatment involving antibodies to Dkk1, a protein linked to amyloid formation in Alzheimer's patients, may protect memory by stopping the disintegration of brain synapses. It won't be useful in people who already have advanced Alzheimer's disease but could potentially slow the rate of cognitive deterioration in those in the early stages of the disease.

Related Summaries